Ensuring equitable access to these effective but high-cost medications, as well as supporting individuals so that they can stay on the therapy long-term, should be a priority for our clinicians and policymakers. Semaglutide, which is approved for managing diabetes, obesity and preventing recurrent cardiovascular events, is already the nations top-selling drug by pharmaceutical spending
These success stories serve as a testament to the effectiveness of this weight loss drug and provide hope and inspiration to individuals looking to embark on their weight loss journey
Our Tirzepatide bulk powder utilizes a customized solid-phase + liquid-phase synthesis process, ensuring not only high purity of Tirzepatide but also achieving 100% bioequivalence to the original sequence through precise control of disulfide bonds and side chains
Learn how to care for your child's IV in the hospital and at home
Medicaid spending on GLP-1s for all conditions increased from $597.3 million for about 755,000 prescriptions in 2019 to $3.9 billion for 3.8 million prescriptions in 2023, according to KFF
The first study (2023) evaluated 7,051 patients undergoing TKA who were prescribed semaglutide preoperatively, comparing them to a matched control group of 34,524 non-users